# Mechanism - Distance Threshold 0.5\n\nExperiment: threshold_0.5_mechanisms\nTotal clusters: 179\nSingleton clusters: 0 (0.0%)\nSilhouette score: 0.069\nDavies-Bouldin score: 0.356\n\n================================================================================\n\n## Cluster 0: Anticoagulation to prevent thromboembolism\n\n**Category**: anti-thrombotic\n**Members**: 2\n\n- anticoagulation to prevent thromboembolic events\n- anticoagulation to prevent thrombus formation\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 7: renal replacement therapy timing adjustment\n\n**Category**: therapeutic intervention\n**Members**: 2\n\n- delayed initiation of renal replacement therapy\n- early initiation of renal replacement therapy\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 8: Antibacterial action against H. pylori\n\n**Category**: antimicrobial\n**Members**: 2\n\n- antibacterial action against H. pylori\n- antimicrobial action against H. pylori\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 10: Cognitive enhancement via neural stimulation\n\n**Category**: Neurocognitive modulation\n**Members**: 2\n\n- cognitive stimulation and improved cognitive performance\n- enhanced cognitive engagement and neural stimulation\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 11: Corticosteroid-mediated anti-inflammatory effects\n\n**Category**: anti-inflammatory\n**Members**: 2\n\n- anti-inflammatory effects through corticosteroid action\n- corticosteroid-mediated anti-inflammatory effects\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 13: Urinary pH reduction via acid excretion\n\n**Category**: Metabolic regulation\n**Members**: 2\n\n- decreased urinary pH through acid excretion\n- decreased urinary pH through increased acid load\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 16: H. pylori eradication with antibiotics\n\n**Category**: antibiotic therapy\n**Members**: 2\n\n- antibiotic treatment to eradicate H. pylori\n- antibiotic treatment to eradicate H. pylori resistant to other antibiotics\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 18: Cell cycle arrest and apoptosis induction in tumor cells\n\n**Category**: apoptosis induction\n**Members**: 2\n\n- cell cycle arrest and apoptosis induction in tumor cells\n- cell cycle inhibition and apoptosis induction in tumor cells\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 23: Antibiotic and bismuth therapy with probiotics for H. pylori eradication\n\n**Category**: antimicrobial\n**Members**: 2\n\n- antibiotic treatment and bismuth to eradicate H. pylori\n- antibiotic treatment and bismuth to eradicate H. pylori, supplemented with probiotics\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 24: Cognitive restructuring and behavioral modification\n\n**Category**: behavioral intervention\n**Members**: 2\n\n- behavioral change through cognitive restructuring\n- cognitive restructuring and behavioral modification\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 44: 5-HT4 Receptor Activation\n\n**Category**: Neurotransmitter Modulation\n**Members**: 2\n\n- activates serotonin 5-hydroxytryptamine receptor 4 (5-HT4) to enhance gastrointestinal motility\n- activation of 5-HT4 receptors to enhance gastrointestinal motility\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 47: Pulmonary clot burden reduction\n\n**Category**: Thrombolytic\n**Members**: 1\n\n- direct reduction of pulmonary artery clot burden\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 48: Early cirrhosis detection and HCC surveillance\n\n**Category**: Disease surveillance\n**Members**: 1\n\n- early detection of cirrhosis and increased participation in HCC surveillance programmes\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 51: CDK4/6 Inhibition\n\n**Category**: cell cycle regulation\n**Members**: 1\n\n- cyclin-dependent kinase 4 and 6 inhibition\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 53: dietary behavior modification through feedback\n\n**Category**: behavioral intervention\n**Members**: 1\n\n- dietary behavior change support through meal logging and nutrient feedback\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 56: early intervention and structured stimulation\n\n**Category**: rehabilitation\n**Members**: 1\n\n- early stimulation and structured interventions\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 61: Immune and cytotoxic effects\n\n**Category**: Immune modulation\n**Members**: 1\n\n- combined immune and cytotoxic effects\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 62: Therapist-Guided Motor Function Exercises\n\n**Category**: rehabilitation\n**Members**: 1\n\n- continuous therapist-guided exercises to enhance motor function and self-efficacy\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 65: HCV replication inhibition\n\n**Category**: Antiviral\n**Members**: 1\n\n- direct-acting antiviral therapy targeting HCV replication\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 67: Acupuncture and Herbal Medicine for Hormonal Regulation\n\n**Category**: hormonal modulation\n**Members**: 1\n\n- combined effect of acupuncture and herbal medicine on hormonal regulation\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 71: Minimally invasive stone removal\n\n**Category**: Surgical intervention\n**Members**: 1\n\n- direct stone removal through minimally invasive surgical access\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 75: Cytotoxic chemotherapy\n\n**Category**: Cytotoxic\n**Members**: 1\n\n- cytotoxic chemotherapy\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 82: Antibacterial action against tuberculosis\n\n**Category**: Antimicrobial\n**Members**: 1\n\n- combined antibacterial action against Mycobacterium tuberculosis\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 83: Infective Vegetation Debulking\n\n**Category**: infectious disease management\n**Members**: 1\n\n- debulking of infective vegetations\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 86: Multi-domain cognitive training\n\n**Category**: cognitive enhancement\n**Members**: 1\n\n- cognitive function improvement through multi-domain training\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 87: sequential H. pylori antibiotic regimen\n\n**Category**: antibiotic therapy\n**Members**: 1\n\n- antibiotic treatment to eradicate H. pylori in a sequential regimen\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 89: GABA modulation and sedation\n\n**Category**: neurotransmitter modulation\n**Members**: 1\n\n- GABA modulation and sedation\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 91: electric field disruption of cancer cell division\n\n**Category**: oncology\n**Members**: 1\n\n- disruption of cancer cell division through electric fields\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 94: Deprescribing and Bone Health Optimization\n\n**Category**: pharmacological intervention\n**Members**: 1\n\n- combined deprescribing and bone health strategies to optimize medication and reduce fall risk\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 95: lymph node metastasis detection via PSMA PET/CT\n\n**Category**: diagnostic imaging\n**Members**: 1\n\n- detection of lymph node metastasis using PSMA PET/CT imaging\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Remaining Clusters\n\nShowing top 30 of 100 total clusters. Remaining 70 clusters not shown (smaller clusters).\n\n